He said: “The company’s strategic location, sophisticated sourcing, regulatory capabilities and broad access to key end markets strengthens our evolving global service offering and will allow us to make a positive difference in the lives of more patients.”
“The company now has significant opportunities to leverage its licensed product sales across Continental Europe as well as expanding into unlicensed products in this market,” the analysts said. “We expect investments will be made to enable this growth and, over time, there is the potential to expand BModesto’s current distribution capacity. This acquisition plays a key role in the execution of Uniphar’s growth strategy.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IrishTimes - 🏆 3. / 98 Read more »